RESEARCH REPORTS
Oil Price Today (November 10): Brent crude falls below $90 for first time in 3 months as Trump says Iran war is effectively over
Crude oil price: Brent crude prices have dropped below $90 per barrel for the first time in nearly three months. US West Texas Intermediate crude futures have also seen declines, slipping to $85 a barrel. President Trump indicated the conflict with Iran is effectively over, suggesting reduced military action is needed. Goldman Sachs has revised its oil price forecasts, predicting potential increases in the coming years.
MRF Q2 Results: Net profit falls 13% YoY to Rs 417 crore, revenue rises 17%; board declares interim dividend
MRF reported a 12.9% YoY decline in consolidated net profit to Rs 417 crore in Q2FY27, despite 17.4% revenue growth. EBITDA fell 14.9%, while the board declared an interim dividend of Rs 3 per share.
Anthropic retracts details of $69 billion IPO filing sent to bankers. Why analysts are raising worries over valuations
Anthropic initially shared its IPO filing details but later retracted the information due to inaccuracies. The company aimed to sell approximately 867 million shares priced between $70 and $80 each. A follow-up email clarified that these pricing details were incorrect. Anthropic indicated that an updated filing would be provided later. The company has chosen not to provide further comments regarding the situation.
'The end customer is Alibaba': Anonymous claim links Malaysia’s YTL AI Cloud to Nvidia–Megaspeed scandal - what’s actually proven
Nvidia Jensen Huang Megaspeed investigation: An anonymous employee cited by short seller Culper Research has claimed Alibaba was the end customer behind a data centre project involving YTL and Megaspeed. The allegation adds to scrutiny of Megaspeed’s Nvidia-powered cloud business as the chipmaker’s board investigates national security concerns involving CEO Jensen Huang.
Market wrap: SBI, Trent, Tata Steel, HCL Tech top gainers and losers on Nifty and Sensex on Monday
Sensex and Nifty ended higher on Monday, extending gains after a recent rally, although profit-booking capped the upside. PSU Bank and Pharma stocks led sectoral gains, while IT shares declined. Market breadth remained negative, with more stocks falling than rising. Nifty reclaimed 25,000, with 25,150–25,200 emerging as resistance.
Can Nifty hit 28,000 before 2028? Citi raises target, sees $12 billion inflows
Citi Research has raised its Nifty 50 target to 28,000 by end-2027, implying 12% upside, citing easing oil prices, stronger foreign inflows and a possible rotation away from AI-heavy investments. The brokerage also sees scope for $12 billion in foreign inflows as global investors increase their exposure to Indian equities.
- Go To Page 1

Market resumes Diwali cheers: Sensex rises 107 points, Nifty ends near 25,050. Why Citi, HSBC are turning bullish?
Sensex and Nifty ended positively after recovering from early losses during the Muhurat Trading session. Nifty PSU Bank index rose significantly, while IT stocks declined, affecting overall market sentiment. Analysts from Citi and HSBC are optimistic about the future of Indian equities amid improving fundamentals. Investors are currently awaiting inflation data to gauge interest-rate trajectories and monitor crude oil prices.

IREDA stock rises 8%, logs seventh straight session of gains; rebounds over 21% from October low
IREDA shares extended their winning streak to a seventh consecutive session on Monday, rising as much as 8% on the NSE. The stock has rebounded over 21% from its October low of Rs 98.78. The rally comes after the company's Q2 results and a recent board-level change.

Nithin Kamath says speculative craziness brought more people into US markets: ‘Nothing expands markets like greed, FOMO
Zerodha CEO Nithin Kamath highlighted the rapid transformation of US financial markets since COVID-19, driven by crypto, derivatives, NFTs and prediction markets. While speculative trading attracts new investors and expands financial participation, Kamath warned that easy access to high-risk investments could harm individuals and society.

Explained: Why Nvidia shares dropped 4% in overnight trade and what analysts warn can trigger a bloodbath?
Nvidia shares dropped over 4% after CEO Jensen Huang acknowledged an affair with Alice Huang. Jensen Huang's relationship with Alice, a Chinese national, raised security concerns following intelligence reports. Nvidia has initiated an investigation into these allegations, although the board believes no secrets were compromised. Analysts suggest the company's upcoming earnings report will be crucial for market sentiment. Concerns linger over Huang's position if further evidence of wrongdoing emerges.

Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoY
Gland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. The stock touched a 52-week high of Rs 3,345, supported by robust CDMO growth, improved margins, new product launches and increased US regulatory approvals.

Honasa Consumer shares climb 5% as Jefferies raises target price after Q2 show. Why is the brokerage bullish?
Honasa Consumer, the firm behind Mamaearth, saw a remarkable boost in its shares after revealing impressive quarterly earnings. The company recorded a nearly 87% increase in consolidated net profit for the September quarter compared to the same period last year. This surge in revenues marked the greatest growth since Honasa’s market debut. Jefferies has also upgraded its target price for the company, citing strong performance and promising future profitability.

Sai Life Sciences shares jump 9%, multibagger stock rallies 19% in 3 days after Q2 results. Why Jefferies hiked target price
Sai Life Sciences shares hit a fresh 52-week high on Monday after strong Q2 results and bullish brokerage commentary. Jefferies retained its Buy rating and raised its target price to Rs 2,050, citing healthy CRO and CDMO growth, a strengthening pipeline and improved earnings prospects.

Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target price by 23% to Rs 12,550, citing robust CDMO business expansion, strong EBITDA margins, and a solid GLP peptide pipeline.

Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?
Divi’s Laboratories shares surged over 8% during Muhurat Trading, hitting a 52-week high after Q2 FY27 net profit jumped 64% to ₹1,127 crore. Revenue grew 35%, while brokerages differed on valuation concerns and future growth prospects.

Finolex Cables shares fall 5% after rallying 20% during Muhurat Trading session. More upside ahead?
Finolex Cables shares fell after a 20% upper-circuit rally during Sunday's Muhurat Trading session, giving back some of the Rs 3,334 crore market-cap gain. The sharp rally followed a strong Q2 performance, with consolidated net profit rising 68% YoY to Rs 273 crore and revenue growing 65% to Rs 2,269 crore.

Oil Price Today (November 9): Crude oil falls below $100 again as Trump says fresh attacks ‘highly unlikely’. What are experts saying?
Crude oil price: Prices came under further pressure after US President Donald Trump indicated that he was unlikely to authorise fresh attacks on Iran if negotiations to end the conflict continued to make progress. In a phone interview with CNN, Trump said further military action was "highly unlikely" to be necessary, provided both sides reached a strong agreement.

Sensex, Nifty end Muhurat Trading session in red for first time in 9 years. Are the bulls losing steam?
Sensex and Nifty erased all early gains and closed in the red following the Muhurat Trading session on Sunday, marking the first time the benchmark indices ended with losses during the special Diwali session in 9 years.

Tata Steel shares jump 3% after Q2 profit rises 16% YoY. Should you buy, sell or hold?
Tata Steel shares surged over 3% during Muhurat Trading after Q2 FY27 net profit rose 16% year-on-year to nearly ₹3,700 crore. Revenue increased 11.5%, while brokerages maintained Buy ratings, citing improving margins and stronger second-half performance prospects.

Coca-Cola’s India bottling arm files draft papers for Rs 9,500 crore IPO
Hindustan Coca-Cola Holdings plans to conduct an initial public offering through an offer for sale of equity shares. The proposed IPO is expected to raise around $1 billion, aiming for a valuation of $10 billion. Coca-Cola Company and Jubilant Bhartia Group hold significant stakes in the company after a recent stake sale. The IPO proceeds will benefit the promoter selling shareholder with no funds directed to Hindustan Coca-Cola Holdings.

Websol Energy Q2 Results: PAT jumps 73% YoY to Rs 80 crore; revenue more than doubles to Rs 361 crore
Websol Energy System reported a 73.2% rise in Q2FY27 net profit to Rs 80.21 crore, while revenue surged 114.6% to Rs 361.02 crore. The company plans a 4 GW solar cell manufacturing expansion at Falta and entry into EPC, solar IPP and energy trading businesses.

Divi's Labs Q2 Results: PAT surges 64% YoY to Rs 1,127 crore; revenue jumps 35%
Divi's Laboratories has achieved a remarkable profit surge of 63.6% year-on-year for the September quarter of FY27, driven by a 35.4% increase in operational revenue, totaling Rs 3,676 crore. The company's total income reached Rs 3,770 crore in Q2FY27, while the first half of the fiscal year saw total earnings hit Rs 6,907 crore.

Bosch announces 1:5 stock split, 3:1 bonus issue. What this means for investors?
Bosch announced its first-ever 1:5 stock split and 1:3 bonus issue alongside Q2 FY27 results. The company reported a 19% YoY rise in consolidated net profit to Rs 839 crore and a 28% jump in revenue to Rs 7,655 crore during the Sept quarter. Here's how the twin corporate actions will affect shareholders' holdings and share price.

Sai Life Sciences shares rally 9% after Q2 results; net profit rises 17%, revenue up 23%
Sai Life Sciences shares jumped nearly 9% to a fresh 52-week high after strong second-quarter results. Revenue rose 23%, while net profit increased 17%, supported by sustained business momentum and growing engagement with global pharmaceutical companies.

Prime Focus shares drop 7% as Ramayana Part 1 makes debut across 5,510 shows today
Prime Focus shares fell as much as 7% as Ramayana made its theatrical debut. Despite high expectations and a reported Rs 4,000-crore budget, early box-office collections came in below trade projections, putting the spotlight on the film's opening performance.

Ather Energy shares fall 4%, snap 5-day gaining streak. What’s triggering the sharp fall?
Ather Energy shares ended a five-session winning streak as the shareholder lock-in period expired, making 21% of its outstanding equity eligible for trading. The development comes after the EV maker reported its first quarterly profit, while Nomura retained its Buy rating.

R&D-focused stocks deliver over 23% annualised returns in five years, outperform NSE 500: Monarch AIF
Indian companies increasing R&D spending outperformed the NSE 500 TRI over five years, delivering 23.5% average annualised returns. Businesses combining strong research growth with higher R&D intensity achieved 32.5%, highlighting innovation's growing importance for investors.

Government has fiscal headroom to absorb Rs 50,000 crore revenue loss from LTCG tax abolition: SBI Research
SBI Research indicates that eliminating the long-term capital gains tax may lead to a modest revenue decline, estimated to be between Rs 40,000-50,000 crore for FY28. The suggested reforms involve raising the exemption limits and introducing lower tax rates based on extended holding durations. Furthermore, an increase in the Securities Transaction Tax is expected to help mitigate some revenue losses, thereby fostering foreign investment and enhancing market confidence.

AI debt surge pushes Magnificent Seven borrowing to $578 billion, up 45%: SBI Research
The combined debt of the seven largest US technology companies, widely known as the Magnificent Seven, has increased nearly 45 per cent to USD 578 billion by mid-2026, raising concerns over the financial risks linked to the rapid expansion of artificial intelligence infrastructure, according to a report by SBI Research.
Load More